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Abstract
The American/Asian genotype of Dengue virus type 2 (DENV-2) was introduced into the Americas in the 809s. Although
there is no data showing when this genotype was first introduced into Brazil, it was first detected in Brazil in 1990. After
which the virus spread throughout the country and major epidemics occurred in 1998, 2007/08 and 2010. In this study we
sequenced 12 DENV-2 genomes obtained from serum samples of patients with dengue fever residing in Sa˜o Jose´ do Rio
Preto, Sa˜o Paulo (SJRP/SP), Brazil, in 2008. The whole open reading frame or envelope sequences were used to perform
phylogenetic, phylogeographic and evolutionary analyses. Isolates from SJRP/SP were grouped within one lineage (BR3)
close to isolates from Rio de Janeiro, Brazil. Isolates from SJRP were probably introduced there at least in 2007, prior to its
detection in the 2008 outbreak. DENV-2 circulation in Brazil is characterized by the introduction, displacement and
circulation of three well-defined lineages in different times, most probably from the Caribbean. Thirty-seven unique amino
acid substitutions were observed among the lineages, including seven amino acid differences in domains I to III of the
envelope protein. Moreover, we dated here, for the first time, the introduction of American/Asian genotype into Brazil
(lineage BR1) to 1988/89, followed by the introduction of lineages BR2 (1998–2000) and BR3 (2003–05). Our results show
a delay between the introduction and detection of DENV-2 lineages in Brazil, reinforcing the importance and need for
surveillance programs to detect and trace the evolution of these viruses. Additionally, Brazilian DENV-2 differed in genetic
diversity, date of introduction and geographic origin and distribution in Brazil, and these are important factors for the
evolution, dynamics and control of dengue.
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Introduction
The four serotypes of dengue virus (DENV 1–4) (family
Flaviviridae, genus Flavivirus) are antigenically and genetically
distinct. DENV has a single-stranded positive-sense RNA genome
of 10,700 nucleotides surrounded by a nucleocapsid and covered
by a lipid envelope containing viral glycoproteins. The RNA
genome contains a single open reading frame that encodes
a precursor polyprotein, which is co- and post-translationally
cleaved into three structural (C, prM and E) and seven non-
structural (NS1, NS2A, NS2B, NS3, NS4A, NS4B, NS5) proteins.
Infection by any DENV serotype can cause an acute self-limited
febrile illness, the classic dengue fever (DF) and/or severe
syndromes characterized by hemorrhage and capillary leakage,
dengue hemorrhagic fever and dengue shock syndrome (DHF/
DSS), according to the old classification system, which is has been
recategorized by the World Health Organization into dengue with
or without warning signs and severe [1–3]. It is estimated that 2.5
to 3 billion people are at risk of DENV infection in more than 100
countries with about 100 million infections and up to 250,000
cases of DHF/DSS worldwide each year [4].
Phylogenetic analyses of dengue virus type 2 (DENV-2) based
on the envelope gene has revealed the existence of six genotypes: (i)
Asian I, (ii) Asian II, (iii) Cosmopolitan, (iv) American, (v)
American/Asian and (vi) sylvatic [5–7]. The Asian/American
genotype groups strains from Southeast Asia in one subclade and
clusters strains from the Caribbean region and Latin America
countries into a second subclade [5,6]. Following the introduction
of the American/Asian genotype to the American continent, likely
from Vietnam into Cuba, the first case of Dengue hemorrhagic
fever was reported in the Americas in 1981 [8]. Since then, the
American/Asian genotype has been responsible for the displace-
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ment of less virulent strains of the American genotype from many
regions of the Americas and also caused major epidemics with
increased pathogenicity on this continent [9–11].
DENV-1 was probably introduced into Brazil in the 809s [12–
13] with the first cases being reported in 1981 in the North region
and later, in 1986 in Rio de Janeiro, Southeast region. DENV-2
was detected in 1990, in Rio de Janeiro [14], but there is no clear
data to indicate when the American/Asian genotype was
introduced into Brazil [15]. Sometime between 1997 and 2000,
DENV-3 was likely introduced into the country [16] and the first
cases were reported in 2000, in Rio de Janeiro [14]. DENV-4 was
probably introduced into the country in 2004–2006 [17], as
suggested by previous isolates in 2005, in the North region [18]
and reemerged in Brazil in 2010–11 [17].
Since the first detection of DENV-2, in Brazil, in 1990, it has
been isolated in 24 of the 26 states in the country. Moreover, an
increase in both the number of epidemics and disease severity has
been observed since its introduction [14;19–20]. DENV-2 has
caused major epidemics in Brazil in 1998, 2007/08, and in 2010.
In 2010 two different lineages of DENV-2 belonging to the
American/Asian genotype were responsible for epidemics in the
country [21–22]. According to the Pan American Health
Organization [23–24], approximately 1.3 million cases of dengue
were reported in the Brazil in 2007 and 2008. More than 17,400
cases of severe dengue and 5,700 cases of DHF were reported
during this period. Six hundred people died from dengue infection
in this two-year period [25–26]. Forty per cent of the total cases
took place in the Southeast region, comprising the states of Sa˜o
Paulo, Rio de Janeiro, Minas Gerais and Espı´rito Santo [25–26].
Additionally, 15% of total cases from Brazil in those years, were
concentrated in Sa˜o Paulo State (more than 104,000 cases of DF,
339 cases of severe dengue, 80 cases of DHF, 12 cases of DSS and
27 deaths) [27]. Sa˜o Jose´ do Rio Preto (SJRP), which is a city
located in the northwestern portion of Sa˜o Paulo state - with a total
area of 431 Km2 and an urban area of 119.5 km2, an estimated
population of 414,272 inhabitants for 2008–presented with more
than 9,500 cases of DF, 40 cases of severe dengue, four cases of
DHF and two deaths caused by DENV infection [28–29], during
the years of 2007 and 2008. DENV-1 transmission was first
reported in SJRP in the early 1990s. Since then, dengue cases have
been reported every year in the city and DENV-2 and DENV-3
were first introduced in 1998 and 2005 respectively [30]. DENV-2
has been circulating since the beginning of the decade in lower or
higher frequencies, despite the major circulation of other
serotypes.
In this study, we sequenced 12 DENV-2 genomes obtained
from serum samples of patients with dengue fever, from SJRP, in
2008, and characterize them at the molecular phylogeographic
and phylogenetic levels. These sequences were compared to
sequences from different genotypes, including sequences from
Brazilian DENV-2 isolates. Analyses were performed to estimate
the degree of genetic variability of DENV-2 in SJRP and Brazil, to
trace the amino acid substitutions in the deduced amino acid
sequences of the entire open reading frame (ORF) and to check
the selection pressures acting on these isolates. Phylogenetic
analyses based on Maximum likelihood and Bayesian methods as
well as coalescent and phylogeographic analyses were performed
(using the entire ORF and/or envelope sequences) to infer the
origin and phylogenetic relationship of these isolates and to trace
the time of introduction of DENV-2 lineages into the country, in
order to gain insights into the dynamics of DENV-2 circulation in
Brazil as well its genetic diversity. Our results demonstrated the
existence of three well-supported DENV-2 lineages in Brazil
differing in genetic diversity, year of introduction, geographic
origin and distribution.
Materials and Methods
Strain and Sample Preparation
The project was approved by the Review Board of Faculdade de
Medicina de Sa˜o Jose´ do Rio Preto (Protocol 6312/2005) and
blood collection was performed with the written informed consent
of the patients. The strains DENV-2/BR/BID-V3653/2008,
DENV-2/BR/BID-V3650/2008, DENV-2/BR/BID-V3638/
2008, DENV-2/BR/BID-V3481/2008, DENV-2/BR/BID-
V3495/2008, DENV-2/BR/BID-V3640/2008, DENV-2/BR/
BID-V3645/2008, DENV-2/BR/BID-V3486/2008, DENV-2/
BR/BID-V3483/2008, DENV-2/BR/BID-V3637/2008, DENV-
2/BR/BID-V3648/2008 and DENV-2/BR/BID-V3644/2008
(GenBank accession numbers GU131885, GU131884,
GU131879, GQ868549, GU131864, GU131880, GU131882,
GQ868551, GQ868550, HM181971, GU131883, GU131881)
were obtained from patients that sought medical care in health
facilities in SJRP/SP, Brazil, in 2008. One hundred and forty ml of
serum were used for RNA extraction using QiAmp Viral RNA kit
(QIAGEN).
cDNA Synthesis and Sequencing
The cDNA was produced with a 20 ml reverse transcription
reaction containing: 1ul Superscript III Reverse Transcriptase
(Invitrogen); random hexamers (1 ml of 50 ng/ml stock); specific 39
reverse primer (1 ml of 10 mM stock) and 5 ml of template RNA.
The 59 primer was used for specific priming of the RT reaction of
samples of DENV-2. Twenty microliters of viral cDNA were
diluted in 800 ml of water, as template for 96 specific PCR
reactions. The 10 ml PCR reaction contained 3 ml of template;
0.03 ml of pfuUltra II polymerase 1 (5 U/ml) (Stratagene);
100 mM dNTPs (Applied Biosystems) and 4 ml of a mixture of
forward and reverse primers (0.5 mM stock) (Table S1). The
primers were synthesized with M13 sequence tags so that PCR
amplicons could be sequenced using universal M13 forward and
reverse primers. The PCR reactions produced 96 overlapping
amplicons, each 500–900 nucleotides (nt) in length, which were
subsequently sequenced bidirectionally using the Big Dye chem-
istry on ABI3730xl DNA sequencers according to Applied
Biosystems protocols, following the same strategy used for
DENV-3 [31] and DENV-1 [13].
Data Sets
The 91 DENV-2 genome sequences used in our analyses were
selected first by retrieving all the DENV-2 complete genome
sequences available in GenBank (April, 2012) and aligning them
using MAFFT [32]. A neighbor-joining tree was then constructed
using Mega 5.0 [33]. We then chose to include all the unique
Brazilian DENV-2 complete sequences (24 genomes) and selected
closely related isolates in the same or neighboring clades, in
addition we included sequences from different decades and finally
we selected reference sequences from the major genotypes; Asian
I, Asian II, Cosmopolitan, American and American/Asian. All
sequences were comprised of the whole coding region of the
DENV-2 genome [10,173 nt, corresponding to the open reading
frame (ORF), from the first nt of the anchored capsid protein gene
to the last nt of the NS5 gene] (Table S2). Additionally, all
Brazilian DENV-2 sequences of the envelope protein (E) gene
were retrieved from the nucleotide database (with the exception of
11 sequences that contained incomplete information regarding
geographic origin within Brazil). The E gene sequences were
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added to the first alignment and used to create an alignment of the
E gene, containing a total of 144 sequences (77 sequences from
Brazilian isolates) of 1495 nt (Table S2). For selection analyses,
another data set was created with 100 ORF sequences from
DENV-2 American/Asian genotype (Table S2). This dataset
contained 21 Brazilian DENV-2 sequences including 8 sequence
isolates from SJRP, excluding identical sequences and based on
the first neighbor-joining tree, other sequences from American/
Asia genotypes were also selected as described (based on the NJ
tree constructed above). The nucleotide substitution model for
each data set was chosen using ModelTest server [34].
Phylogenetic Analyses
Maximum Likelihood trees were constructed using the align-
ment containing 91 DENV-2 complete ORF sequences using the
General Time Reversible model and Gamma distribution (GTR
+G) implemented in MEGA 5.0 [33]. Rates of variation among
sites were estimated for each dataset and four discrete Gamma
categories were used to model evolutionary rate differences among
sites. The reliability of branching patterns was tested through 1000
bootstrap sampling. To include a greater number of Brazilian
sequences, phylogenetic analyses were also performed using the
alignment containing 144 sequences of the DENV-2 E gene. Using
this later data set, Maximum likelihood trees were reconstructed
using MEGA 5.0 [33] as previously described, using the Tamura
Nei model and Gamma distribution (TN93+ G).
Genetic Diversity and Selection Analyses
Estimates of the evolutionary divergence within and among
different lineages were calculated based on 77 envelope sequences
of Brazilian DENV-2 isolates. The mean distance, given by the
number of base substitutions per site from all sequence pairs within
or among different lineages was computed using the Tamura-Nei
model implemented in Mega 5.0 [33] and values were further
converted into percentage. The HyPhy package in Datamonkey
webserver (www.datamonkey.org) [35] was used to check the
selection pressures on the codons of the entire ORF of DENV-2,
using different methods: single-likelihood ancestor (SLAC), fixed–
effects likelihoods (FEL), internal branch fixed-effects likelihood
(IFEL) and FUBAR. The GTR model was used and significance
levels of p,0.05 (SLAC, FEL, IFEL), or posterior probability
.0.9 (FUBAR) were chosen for the analyses.
Bayesian Coalescent and Discrete Phylogeographic
Analyses
Time of the most recent common ancestor (MRCA) for some
lineages was estimated using BEAST package v.1.6.1 with Markov
Chain Monte Carlo algorithms [36]. Input files for BEAST were
created with BEAUTi graphical interface [37] based on 144
sequences of the E gene, including sequences from all genotypes,
excepting the sylvatic genotype (Table S2), and a total of 77
Brazilian sequences. The calibration point was the year each strain
was isolated/obtained. Runs were performed using the Bayesian
Skyline plot, under strict or relaxed (uncorrelated lognormal)
molecular clock, and using the estimated rate of 7.5061024
substitutions per site, per year, as previously described [38]. One
hundred million chains were run and the first 10 million steps were
discarded. Convergence of parameters was verified with Tracer
v.1.5.0 [39] and uncertainties were addressed as the 95% highest
probability density (HPD) intervals. The trees were sampled at
each 5,000 steps, resulting in 18,000 trees, which were summa-
rized in a maximum clade credibility tree using TreeAnotator
v.1.6.1 [40] that was then visualized in FigTree v.1.3.1 [41]. This
analysis was also carried out using the smaller dataset, containing
91 ORF sequences.
For phylogeographic inferences, based on the 144 sequences of
the E gene, the analyses were performed using a standard
continuous-time Markov chain (CTMC) and a Bayesian stochastic
search variable selection (BSSVS) procedure that identifies the
parsimonious descriptions of the diffusion process [42]. A
constant-size coalescent process prior was assumed since Bayesian
skyline plot model may have little influence on the phylogeo-
graphic inference [42]. A geographic location attributed was
added to each taxon and the Brazilian DENV-2 isolates were
categorized according to their geographic origin in Brazil (North,
Northeast, South and Southeast regions). Additionally, a Bayes
factor test was performed in order to identify well-supported rates
to explain the diffusion process, using the platform SPREAD
(spatial phylogenetic reconstruction of evolutionary dynamics)
[43]. Rates yielding a Bayes factor higher than 3 were considered
well supported diffusion rates [42]. The posterior distribution of
ancestral location states was summarized using TreeAnotator
v.1.6.1 [40] and the modal location state for each node was
annotated on the maximum clade credibility tree using FigTree
v.1.3.1 [41].
Results
Phylogenetic analyses, based on the genome sequence, demon-
strate that all Brazilian and other isolates from Central and South
America and from the Caribbean grouped within American/Asian
genotypes apart from strains from Southeast Asia (Figure 1).
Brazilian strains are subdivided into three well-supported lineages
(bootstrap values of 100%), which are placed in two different
clades (Figure 1). Lineage BR1 groups two Brazilian strains
isolated in 1998 and 2000 that also clusters strains from
Venezuela, Colombia and Puerto Rico, isolated from 1990 to
1998. Lineage BR2 contains strains isolated from 2000 to 2006, in
the Northern region of the country and these sequences are closely
related to strains isolated in 1998 in Puerto Rico. Finally, the 12
DENV-2 strains sequenced here cluster together with two
Brazilian strains from the North region, in a lineage, called
BR3. These strains also cluster with a strain isolated in Jamaica in
2007. When a greater number of E sequences were included (total
of 144 E sequences including 77 E sequences from Brazilian
isolates), similar clustering patterns are observed in the Maximum
likelihood tree (data not shown).
The 14th codon position in the NS3 gene, shows positive
selection using all methods (with dN/dS .1 and p-values ,0.05
for SLAC, FEL and IFEL, and posterior probability = 1.0 for
FUBAR). When 77 predicted protein envelope sequences from
Brazilian isolates were analyzed, seven amino acid (aa) substitu-
tions are observed in domains I to III of this protein, differentiating
the three lineages (Table 1).
Amino acid (aa) substitutions are observed in the deduced aa
ORF sequences and some of them are unique to some lineages
(Table S3). For BR1, 16 aa substitutions are observed in the
deduced protein sequences [capsid (106I), membrane (134A),
envelope (131L, 160E, 203E, 347A), NS2a (62V, 133V, 162L,
189T), NS3 (115L, 418R, 549R), NS5 (375R, 429S and 670L)]
(Table S3); in BR2, six aa substitutions are observed [envelope
(61V), NS2a (108V, 138K), NS3 (77V) NS5 (656T, 676N)] (Table
S3) and finally, in BR3, 15 unique aa substitutions are observed
[envelope (129I, 170T, 340T), NS1 (5I), NS2a (38L), NS3 (561K),
NS4a (36V, 42T), NS4b (15F) and NS5 (5V,388E, 521E, 523G,
596K and 637A) (Table S3). One aa substitution is exclusive to 11
strains isolated in SJRP/SP in the NS5 sequence (position 874M)
Characterization of DENV 2 Circulation in Brazil
PLOS ONE | www.plosone.org 3 March 2013 | Volume 8 | Issue 3 | e59422
Characterization of DENV 2 Circulation in Brazil
PLOS ONE | www.plosone.org 4 March 2013 | Volume 8 | Issue 3 | e59422
(Table S3). The aa substitution (63A) in the NS4a sequence is only
observed in sequences obtained in SJRP/SP and another isolate
from Rio de Janeiro (BR-BIDV2399/2007) (Table S3). Five aa
substitutions [at M/prM (83T), E (129H), NS4a (64V), NS4b (17S)
and at NS5 (891R)] are common to JM/BID-V2963/2007, US/
BID-V1439/2005, VI/BID-V2960/2005 and all Brazilian isolates
within BR3, with the exception of BR/BID-V2402/2008.
The estimate of average evolutionary divergence within the 12
strains from SJRP/SP is 0.074% 60.012, based on the ORF
sequence. The most divergent sequence is BR-BID-V3644/2008
when compared to the other 11 isolates. The nucleotide sequences
from the whole ORF of four isolates BR/BID-V3653/2008, BR/
BID-V3638/2008, BR/BID-V3640/2008 and BR/BID-V3483/
2008 are identical to each other. The estimates of evolutionary
divergence within each Brazilian lineage based on envelope
sequences are BR1 = 1.05% 60.11 (n = 32 sequences),
BR2 = 0.6860.14 (n = 8 sequences) and BR3 = 0.3560.076
(n = 37 sequences). The estimates of evolutionary divergence
among lineages BR1, BR2 and BR3 ranged from 2.77% 60.40 to
3.10% 60.39.
The coalescent analyses were performed with a dataset contain-
ing 144 E sequences using the strict or relaxed (uncorrelated
lognormal) molecular clock. Both analyses presented similar values
(Table S4) and reached effective sample sizes .200 for all
parameters and the results for the relaxed molecular clock are
presented here. Based on the later analysis, the estimated mean
overall substitution rate for the tree given in substitutions/site/
year (ssy) ranged from 8.5561024 to 1.0061023 (95% HPD).
Additionally, the MRCA of Latin America strains and the strain
from Vietnam (VN/BID-V2947/1988) is estimated to have
existed in 1979 [95% HPD = 1976–1982 (30.7960.009 years
before 2010, with 95% HPD = 28.15–33.83 yrs)] (Figure 2a), while
the MRCA of all American/Asian genotype isolates probably
existed in 1975 [95% HPD = 1971–1980 (34.5760.01 years
before 2010, with 95% HPD = 30.53–38.70 yrs)].
Similar clustering patterns of Brazilian DENV2 isolates were
observed (Figure 2A) when compared to phylogenetic analyses
(Figure 1), reinforcing the existence of three distinct Brazilian
DENV-2 lineages. Lineage BR1 contains the oldest isolates and its
MRCA is estimated to date at 1989 [95% HPD = 1988–1989
(20.9460.002 years before 2010, with 95% HPD = 20.30–
21.67 yrs)] These Brazilian strains comprise 32 isolates from
1990 to 2003, from different regions of the country including the
South, North, and Northeast but predominantly from the
Southeast (Figure 2 a and b). The MRCA of lineage BR1 is
inferred to be from Southeast Brazil (Figure 2a) (posterior
probability = 0.96) and this lineage is closely related to strains
from Colombia, Venezuela and Puerto Rico sharing a MRCA
with these later sequences dating at 1987 [95% HPD = 1986–1988
(22.3960.004 years before 2010, with 95% HPD = 21.33–
23.56 yrs)] (Figure 2a). When the MRCA of BR1 was estimated
on the complete ORF sequence (based on sequences of only two
isolates, BR/BID-V2376/2000 and BR64022/1998) it was
calculated to have existed in 1995 [95% HPD = 1993–1997
(13.2960.1 years before 2009, with 95% HPD = 11.50–15.53 yrs)]
(data not shown). The MRCA for these two Brazilian DENV-2
isolates (BR/BID-V2376/2000 and BR64022/1998) was also
calculated based on the E sequence and it is also estimated to have
existed in 1995 [95% HPD = 1992–1997 (14.5360.04 years
before 2010, with 95% HPD = 12.76–17.47 yrs)] (data not shown).
Eight Brazilian isolates are clustered within lineage BR2,
including strains obtained from 2001 to 2006 in the Northern
region (Figure 2a and b). The MRCA of BR2 is estimated to be
from Northern Brazil (Figure 2a) (posterior probability = 0.96),
dating at 1999 [95% HPD = 1998–2000 (11.0060.003 years
before 2010, with 95% HPD = 10.17–11.92 yrs)] (Figure 2a). The
MRCA of BR2 estimated on the complete ORF sequence is also
calculated to have existed in 1999 [95% HPD = 1998–2000
(10.0660.01 years before 2009, with 95% HPD = 9.31–10.88 yrs)]
(data not shown). This lineage is closely related to two strains from
Puerto Rico, sharing a MRCA estimated to date at 1996 [95%
HPD = 1994–1997 (13.9760.004 years before 2010, with 95%
HPD = 10.19–11.93 yrs)] and inferred to be from Puerto Rico
(Figure 2a) (posterior probability = 0.60).
Lineage BR3 is the youngest lineage grouping 37 strains isolated
from 2007 to 2010 mainly in the Southeast and also North and
Northeast regions of the country (Figure 2a and b). These
Brazilian isolates are closely related to a strain from Jamaica
sharing the MRCA with this later strain (JM/BID-V2963/2007),
which probably dates at 2004 [95% HPD = 2003–2005
(5.7460.004 before 2010, with 95% HPD = 4.68–6.97 yrs)
(Figure 2a). The MRCA of BR3 estimated on the complete
ORF sequence was calculated to have existed in 2005 [95%
HPD = 2004–2006 (3.4160.01 years before 2009, with 95%
HPD = 2.57–4.24 yrs)] (data not shown). Isolates from BR3 and
Jamaica (JM/BID-V2963/2007) are also closely related to strains
Figure 1. Phylogenetic analysis of DENV-2 based on the complete genome sequence. The evolutionary history was inferred using the
Maximum Likelihood method, using the General Time Reversible model for nucleotide substitution with discrete Gamma distribution to model
evolutionary rate differences among sites [4 categories (+G, parameter = 0.45)]. The tree with the highest log likelihood (246330.60) is shown. The
tree is drawn to scale, with branch lengths measured in the number of substitutions per site. The analysis involved 91 nucleotide sequences with
a total of 10,167 positions in the final dataset. A total of 1000 bootstrap replicates were run and values $99 are represented as percentage in
respective nodes. The Brazilian DENV-2 lineages are shown in grey. For clarity purposes some branches were collapsed. VE/CO/GU/BZ/MX 1999–2009
contains isolates from Venezuela (VE61095/2007, DENV-2/VE/BID-V2944/2005, -V2424/2004, -V2492/200, -V2216/2003, -V2262/2006), Colombia
(DENV-2/CO/BID-V3370/2004, -V3369/1999, -V1603/2004), Guatemala (FDA-GUA09/2009), Belize (BZ/BID-V2952/2002) and Mexico (DENV-2MX/BID-
V3661, -V3714 and –V3768); PR 1986–1995 contains isolates from Puerto Rico (DENV-2/US/BID-V1356/1993, -V855/1992, -V1182/1989, -V1175/1988, -
V1183/1990, -V1171/1987, -V1164/1986, DENV-2/PR/17DN/1995 and DENV-2/PR/6780DN/1994 ) and PR 1994–2007 also contains isolates from Puerto
Rico (DENV-2/US/BID-V37DN/1994, -V1424/1996, -V1427/1999, -V1398/1997, -V1038/1998, -V1367/1995, -V1463/2000, V1472/2001, -V593/2005 and –
V1412/2007). Evolutionary analyses were conducted in MEGA5.0.
doi:10.1371/journal.pone.0059422.g001
Table 1. Amino acid differences in the envelope protein of
Brazilian DENV-2 lineages.
Lineage Amino acid position and localization in protein E
61
(DII)
129
(DII)
131
(DII)
170
(DI)
203
(DII)
340
(DIII)
380
(DIII)
BR3 I I Q T D T V
BR2 V V Q I D M I2
BR1 I V L I E1 M I
1- except HQ012515.BR59382/RN/1997 and HQ012518.BR66985/RJ/2000 (K).
2- except DENV-2/BR/BID-V2386/2003, DENV-2/BR/BID-V2396/2006,
JF804028.BR/DB015/2006 (V).
doi:10.1371/journal.pone.0059422.t001
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isolated in Puerto Rico (US/BID-V1439/2005) and the Virgin
Islands (VI/BID-2960/2005) with an estimated date for the
MRCA of 2003 [95% HPD = 2001–2004 (6.9960.02 years before
2010, with 95% HPD = 5.57–8.77 yrs) (Figure 2a). These isolates
altogether plus another one from the Dominican Republic
(DR59/2001) share the MRCA inferred to be from the
Dominican Republic (Figure 2a) (posterior probability = 0.87)
and it probably dates at 2001 [95% HPD = 2000–2001
(9.060.001 years before 2010, with 95% HPD = 9.0–9.59 yrs)
(Figure 2a).
All strains from SJRP/SP, except BR/BID-V3644/2008, have
a common ancestor estimated to date at 2007 [95% HPD = 2006–
2008 (2.8760.003 years before 2010, with 95% HPD = 2.15–
3.53 yrs)] (Figure 2a). All strains from SJRP/SP and two strains
from the North and Southeast regions (BR/BID-V2399/2007 and
BR0690/RJ/2008) have a MRCA probably from Southeast Brazil
(Figure 2a and b) (posterior probability = 1.0) dating at 2005 [95%
HPD = 2004–2006 (4.3760.003 years before 2010, with 95%
HPD = 3.39–5.31 yrs)] (Figure 2a).
Well-supported diffusion rates with Bayes Factor (BF) higher
than 3 (data not shown) are observed supporting different
migration pathways among countries from Central America
(Mexico, Belize and Guatemala), among the Caribbean island
countries (Dominican Republic, Virgin Islands, Puerto Rico, Saint
Kitts and Nevis, Jamaica, Cuba and Martinique) and between
Venezuela and Colombia. Well-supported rates supporting
different migration pathways within Brazil are also observed, such
as between the Northeast and Southeast (BF.3000), between the
North and Southeast (BF = 27) and between the Northeast and
South (BF = 12). Additionally, it is also noted that there is
a migration pathway with a well-supported rate (BF = 4) between
Northern Brazil and the Virgin Islands.
Discussion
Our study demonstrates that the isolates from SJRP/SP all
group within the American/Asian genotype together with isolates
from South and Central America and the Caribbean, as previously
demonstrated for other Brazilian isolates [21–22;44]. This
genotype was most probably introduced into the Americas from
Vietnam via Cuba, approximately 30 years ago [8]. Indeed, our
estimates for the MRCA for the Latin America cluster plus one
Vietnam strain as well as the MRCA for the American/Asian
genotypes are in agreement with previous findings [8;45–46],
thereby supporting our current results.
Brazilian isolates were subdivided into three well-defined
lineages and 37 unique aa substitutions were mapped to the
predicted protein sequence from the entire ORF that character-
ized and differentiated these lineages. In particular some aa
differences were observed in the deduced envelope protein
sequences unique among BR1, BR2 and/or BR3: three aa
differences were observed between BR1 and BR2, five aa
differences were observed between BR2 and BR3 and finally, six
aa differences were observed between BR1 and BR3. Although,
none of those aa differences in the envelope sequence were
associated with positively selected codons in this study, they were
located in the domains I, II and III [47] which are known to be
involved in the production of neutralizing antibodies against
DENV in vivo or in vitro [48–50]. Moreover, residue 131 is located
within a pH-dependent hinge region at the interface between
domains I and II of the protein, and mutations in this region may
affect the pH threshold fusion of envelope protein to membrane of
the target cell [47]. It is possible that the introduction and
establishment of different DENV-2 lineages in Brazil could have
been favored by aa differences that were involved in the
immunologic escape from antibodies produced against previous
DENV-2 lineages, by co-circulating DENV-1 and DENV-3,
[14,16] or even due to stochastic events [6].
The oldest lineage, BR1, is estimated to have been introduced
between 1988 and 1989. This lineage contains strains isolated
from 1990 to 2003, from a wider geographic region and represents
a longer time period (14 years) than the other lineages. BR1 also
has the highest values with regard to genetic diversity followed by
BR2 and then BR3. The isolates responsible for the epidemics in
1990 and 1998 were clustered within this lineage. In 1990, an
epidemic outbreak took place in Rio de Janeiro one or two years
after the estimated date of introduction of the American/Asian
genotype into the country. During this outbreak, severe illness and
fatal cases were observed and the virus spread throughout the
country [12;19–20]. During the epidemic in 1998, more than
528,000 dengue cases were registered in Brazil [51] with the
occurrence of more severe clinical presentations when compared
to DENV-1 outbreaks [14]. Within BR1, there is no clear division
between the strains from the 1990 and 1998 epidemics, however
the 1990–1991 strains are basal to later strains and suggest local
evolution up to 2003. This was also observed in other studies,
suggesting that viruses circulating in the 1990 and 1998 epidemics
belong to the same lineage, most likely introduced in Rio de
Janeiro (Southeast regions) [21–22;44], from neighboring South
America countries such as Venezuela and Paraguay [22]. In fact,
the MRCA of lineage BR1 was estimated to be from Southeast
Brazil supporting the idea that this lineage was probably
introduced into that region and then disseminated to other parts
of the country, which is also in accordance with its geographic
occurrence in four different regions and with the inferred
migration pathways of DENV-2 within the country. Additionally,
a close relationship between lineage BR1 and strains from South
American countries (Venezuela and Colombia) as well as Puerto
Figure 2. Bayesian coalescent and discrete phylogeography analyses of Brazilian DENV-2 based on envelope nucleotide sequence.
Subtree of the maximum clade credibility tree was inferred using 144 DENV-2 envelope sequences (1,485 nt). The subtree containing isolates of the
American/Asian genotype is displayed here. Time of the most recent common ancestor (MRCA) was estimated using the year of isolation as the
calibration point, under the relaxed molecular clock, with the Tamura Nei Model, with discrete Gamma distribution and an estimated nucleotide
substitution rate of 7.524. The posterior probabilities values $0.96 are represented by (*) and values $0.99 are represented by (**), inside the nodes.
The years that the MRCA was estimated to exist are shown for some nodes with upper and lower intervals in parenthesis. The origin value of the
reverse scale axis corresponds to year 2010. Using different colors, (legend shown on the left side), terminal branches were annotated based on
geographic location of DENV-2 isolates. Internal nodes of the tree which presented modal state posterior probability $0.60 were also colored
according to their most probable location states, inferred by discrete phylogeographical analysis. Brazilian lineages are delimited by square brackets.
For clarity purposes some branches were collapsed. SJRP/2008 contains 11 isolates from Sa˜o Jose´ do Rio Preto/Sa˜o Paulo/Brazil (DENV-2/BR/BID-
V3653/2008, -V3638/2008, -V3640/2008, -V3483/2008, -V3637/2008, -V3495/2008, -V3645/2008, -V3481/2008, -V3486/2008, -V3650/2008 and -V3648/
2008); CU/US/KN 1997–2001 contains isolates from Cuba (Cuba115/97 and Cuba165/1997), Puerto Rico (US/BIC-V1387/1998) and Saint Kitts and Nevis
(KN/BID-V2951/2001); VE/CO/GU/BZ/MX 1999–2009; PR 1986–1995 and PR 1994–2007 contain the same isolates as described in the Figure 1 caption.
Analyses were performed using programs from BEAST package v.1.6.1, BEAUTi, Tracer v.1.5.0, TreeAnotator v.1.6.1 and FigTree v.1.3.1 (B) Map of Brazil
showing the macro-regions and states. The black pin indicates the approximate location of Sa˜o Jose´ do Rio Preto/Sa˜o Paulo/Brazil.
doi:10.1371/journal.pone.0059422.g002
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Rico was observed. Although it was not possible to confirm the
epidemiological linkage between Brazil, Venezuela, Colombia or
Puerto Rico, this region appears to be a possible ancestral location
of strains circulating in South America countries.
BR2 is the second oldest lineage, estimated to have been
introduced in Northern Brazil probably from Puerto Rico between
1998 and 2000 and it was not associated with any major reported
epidemics. This lineage was restricted to Northern Brazil with only
eight sampled strains from 2000 to 2006. Previous studies have
demonstrated that serotype and/or genotype co-circulation in
a particular region and serotype displacement may result in
complex patterns of competition, affecting population diversity
and lineage turnover [52–53].The introduction of DENV-3 in the
Southeast region, likely in 1999 and then in the North region of
the country in 2001 [16] could be responsible for the restricted
circulation of BR2 at that time. Likewise, this later scenario is also
in agreement with the conditions observed during the last DENV-
2 epidemics in Brazil (2007/08 and 2010) which may explain the
emergence of lineage BR3: a shift from the DENV-3 to DENV-2
prevalence in Southern Brazil and the introduction (at least in
2005) and emergence (in 2007) of a genetically distinct lineage
[22].
BR3 is the most recent lineage to emerge in Brazil, grouping
isolates circulating from 2007 through at least 2010, primarily
from the Southeast region (particularly Sa˜o Paulo and Rio de
Janeiro states). Some studies suggested that lineage BR3 has been
introduced into Brazil from the Caribbean [22,44]. Our results
demonstrate that isolates JM/BID-V2963/2007 (from Jamaica),
VI/BID-V2960 (from Virgin Islands) and US/BID-V1439/2005
(from Puerto Rico) are the closest strains to lineage BR3. Although
a possible migration pathway for DENV-2 between Northern
Brazil and the Virgin Islands was observed it was not possible to
identify (with statistic support) if any of these countries is the
ancestral location of the MRCA of BR3. On the other hand, all
these strains together in addition to a strain from the Dominican
Republic probably have a MRCA from this later country, dating
at 2001 giving support to the idea that lineage BR3 originated
from the Caribbean.
Our results are in agreement with previous estimates that
indicated that this lineage was already circulating in the country
before its first detection in 2007 [22]. Similar patterns of
introduction/detection were also observed for DENV-2 lineages
BR1 and BR2 in this study, for DENV-1 [13] and DENV-3 [16]
in Brazil and for DENV serotypes (1 to 4) in the Americas [53].
This delay between the introduction of DENV in a region and its
detection could be explained by the fact that viruses can remain
undetected until the number of infections and/or disease incidence
reaches a threshold of detection that is high due to poor
surveillance in most countries in the Americas [46].
Coalescent analysis performed on envelope sequences demon-
strated that within lineage BR3, there is a subdivision with BR/
BID/V-2402/2008 and JM/BID-V2963/2007 being more related
to each other and sharing a common ancestor at 2004/05
(5.38 yrs before 2010) while all other isolates within BR3 share
a common ancestor at 2005 (4.82 yrs before 2010), probably from
Southeast Brazil. Based on these findings and the five aa
substitutions that are common to JM/BID-V2963/2007, US/
BID-V1439/2005, VI/BID-V2960/2005 and all Brazilian isolates
within BR3, excepting BR/BID-V2402/2008, it is probable that
strains circulating in the Southeast region did not directly originate
from BR/BID/V-2402/2008, detected in the Northern region.
This is also supported by the observation of two unique aa
substitutions [NS4a (63A) and at NS5 (412V)] observed in all
sequences from BR3 with the exception of BR/BID-V2402/2008.
One can speculate that this lineage might have been introduced
into Brazil by two parallel events or that after the introduction, the
virus disseminated through the country, which is also supported by
the different inferred migration pathways of DENV-2 within the
country, and it has been locally evolving giving rise to different
strains, in the North and Southeast regions. We observed that
isolates from SJRP/SP formed a homogeneous group with low
genetic diversity and the most divergent strain was BR-BID-
V3644/2008. Isolates from SJRP/SP were close to isolates from
Rio de Janeiro, having been introduced into SJRP/SP, probably
from Southeast Brazil, at least by 2007, prior to detection in the
2008 outbreak in SJRP/SP.
DENV-2 circulation in Brazil is characterized by introduction
of three different lineages over time, most probably from the
Caribbean. The Caribbean region and other South American
countries have been proposed to be the main sources of DENV
introduction into Brazil [22,46]. The close geographic proximity
of the Northern region to Caribbean countries favors the
introduction of DENV from the Caribbean into that region
[16], with similar situations being valid for different regions of
Brazil and their neighboring countries [13,21,22,44,54]. The
Southeast region, and especially the state of Rio de Janeiro has
been considered to be the most important point of DENV
introduction into the country, since this was the state where the
first cases of DENV-1, DENV-2 and DENV-3 were reported [14].
Southeast Brazil concentrates the largest and the most densely
inhabited cities/states, including Sa˜o Paulo and Rio de Janeiro.
These states contain the most important airports in the country
and they are also well connected to other regions via land
transport systems [16]. It’s likely that lineages BR1 and BR3 were
first introduced to and/or disseminated through the Southeast
region, which might be one of the factors contributing to the
apparent greater distribution of these lineages throughout the
country. Dengue outbreaks that took place in Brazil in 2007/2008
and 2010, related to lineage BR3, were more severe in terms of
overall number of cases, and number of severe cases as well as
number of deaths, than the previous DENV-2 epidemics in 1990
and 1998, which were related to lineage BR1. It is possible, given
the severity of the more recent epidemics, that in addition to the
co-circulation of DENV-1 and DENV-3 during these years, the
genetic characteristics of DENV-2 BR3 could have contributed to
different biological characteristics, which in turn might have
played a role in the displacement of other serotypes or lineages
circulating in some regions of the country.
In Brazil, the co-circulation of different lineages has been
demonstrated for DENV-1 and DENV-3 [13,16] and co-
circulation of different genotypes has been demonstrated for
DENV-4 [17]. However, in case of DENV-2, the introduction of
new lineages was associated with the displacement of the old
lineage and the emergence of a new one. Apparently, the co-
circulation of DENV-2 BR1 and BR2 occurred for only a short
period of time. This pattern is dissimilar to the DENV-2 dynamics
observed in Puerto Rico, where different lineages co-circulate and
one endemic strain seems to be refractory to influences from
frequent foreign DENV-2 strains [55].
Phylogenetic analyses have demonstrated a constant clade or
lineage turnover process in DENV dynamics [52,56]. In addition
to the introduction and co-circulation of different serotypes,
genotypes or lineages, that may have different spatiotemporal
distributions, the lineage replacements might be associated with
epidemic outbreaks. Indeed, major epidemic outbreaks took place
a few years after the introduction of BR1 and BR3 into the
country. The high migration rates of DENV-2 between the
Caribbean, Central and South America and even throughout
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Brazil, in addition to the observed delay between the introduction
of a new virus (serotype/genotype/lineage) in one area and its
detection, reinforces the need for surveillance programs in these
regions in order to detect and trace the evolution of these viruses as
soon as possible. This could help to establish measures to prevent
significant outbreaks and to lower the number of severe dengue
cases and deaths. Moreover this genetic diversity also should be
taken into account in dengue control programs, since the valuation
of vaccine efficacy should consider different epidemiological
situations added to a range of dengue viruses with distinct
virulence and viral fitness circulating in both epidemic and
endemic context [57]. Finally, our data indicate the existence of
three well-supported DENV-2 lineages in Brazil and we also
dated, for the first time, the introduction of the American/Asian
genotype into Brazil. The Brazilian DENV-2 lineages differed in
genetic diversity, year of introduction, origin and geographic
distribution in Brazil, which are important features when
considering evolution, dynamics and control of dengue and
dengue viruses.
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